Ling Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ling Wang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Ping Gong
Department of Emergency Medicine, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), China
4 shared publications - Dongping Yu
Department of Emergency, The Second Affiliated Hospital of Dalian Medical University (Dalian Medical University Cancer Hospital), Dalian, Liaoning, China
2 shared publications - Peijuan Li
Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to, Shandong First Medical University, Jinan, China
2 shared publications - Yushu Chen
Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology) , Shenzhen, China
2 shared publications - Beibei Jin
Department of Emergency Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, China
1 shared publication - Chundong Gu
Department of Thoracic Surgery The First Affiliated Hospital of Dalian Medical University Dalian China
1 shared publication
Latest Publications
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 483
Role of eCIRP in Mediating Post-ischemia Microglial Phagocytosis via TREM-2 Receptor: Insights from Porcine and Mouse Cellular Models
Cerebral ischemia/reperfusion (I/R) injury triggers potent neuroinflammatory responses, in which microglial activation and dysregulated phagocytosis may contribute to neuronal damage. Extracellular cold-inducible RNA-binding protein (eCIRP), a damage-associated molecular pattern, has been implicated in postischemic inflammation; however, its role in regulating microglial phagocytosis remains poorly understood. This study employed a porcine model of cardiac arrest/reperfusion (CA/R) and a mouse cellular model of oxygen–glucose deprivation/reoxygenation (OGD/R) in BV2 microglia and N2a neuron to investigate the role of the eCIRP–TREM2 signaling in microglial activation. We evaluated protein expression and direct interaction between CIRP and TREM2 by Western blotting, immunofluorescence, co-immunoprecipitation, and surface plasmon resonance (SPR), while assessing phagocytic activity by fluorescent microsphere uptake and synaptic protein expression assays. Both CA/R and OGD/R conditions significantly elevated the levels of CIRP expression and activation of the TREM2–DAP12–Syk–ERK1/2 signaling. Treatment with recombinant human CIRP (rhCIRP) further increased the expression of microglial activation markers and enhanced phagocytic activity, accompanied by reducing the expression of synaptic proteins. These effects were partially mitigated by CIRBP or TREM2 silencing, or ERK inhibition. Our findings support a novel hypothesis that eCIRP may bind to TREM2 and activate downstream signaling in microglia, enhancing their phagocytic responses in the process of I/R-induced neuronal injury. The eCIRP–TREM2 axis may thus represent a potential therapeutic target for modulating neuroinflammation and preserving neuronal integrity.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 483
Role of eCIRP in Mediating Post-ischemia Microglial Phagocytosis via TREM-2 Receptor: Insights from Porcine and Mouse Cellular Models
Cerebral ischemia/reperfusion (I/R) injury triggers potent neuroinflammatory responses, in which microglial activation and dysregulated phagocytosis may contribute to neuronal damage. Extracellular cold-inducible RNA-binding protein (eCIRP), a damage-associated molecular pattern, has been implicated in postischemic inflammation; however, its role in regulating microglial phagocytosis remains poorly understood. This study employed a porcine model of cardiac arrest/reperfusion (CA/R) and a mouse cellular model of oxygen–glucose deprivation/reoxygenation (OGD/R) in BV2 microglia and N2a neuron to investigate the role of the eCIRP–TREM2 signaling in microglial activation. We evaluated protein expression and direct interaction between CIRP and TREM2 by Western blotting, immunofluorescence, co-immunoprecipitation, and surface plasmon resonance (SPR), while assessing phagocytic activity by fluorescent microsphere uptake and synaptic protein expression assays. Both CA/R and OGD/R conditions significantly elevated the levels of CIRP expression and activation of the TREM2–DAP12–Syk–ERK1/2 signaling. Treatment with recombinant human CIRP (rhCIRP) further increased the expression of microglial activation markers and enhanced phagocytic activity, accompanied by reducing the expression of synaptic proteins. These effects were partially mitigated by CIRBP or TREM2 silencing, or ERK inhibition. Our findings support a novel hypothesis that eCIRP may bind to TREM2 and activate downstream signaling in microglia, enhancing their phagocytic responses in the process of I/R-induced neuronal injury. The eCIRP–TREM2 axis may thus represent a potential therapeutic target for modulating neuroinflammation and preserving neuronal integrity.
- Open Access
- 21 August 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (8) , e70495
Oseltamivir Phosphate Modulates CD24‐Siglec‐G/10 Interaction to Suppress Microglial‐Driven Neuroinflammation After Cardiac Arrest
Background: In cardiac arrest (CA) patients undergoing cardiopulmonary resuscitation (CPR), neuroinflammation following return of spontaneous circulation (ROSC) contributes to brain ischemia/reperfusion injury and neurological dysfunction. Recent evidence suggested that neuraminidase could exacerbate inflammatory responses by disrupting CD24‐Siglec‐G/10 immune checkpoint axis. As a neuraminidase inhibitor, oseltamivir phosphate (OP) holds potential for immunomodulation beyond its antiviral use. We aimed to investigate the impact and mechanism of OP on neuroinflammation regulation after ROSC.Methods: Male pigs were randomized into the sham control group, CPR, and CPR + OP group. CA was induced in pigs through 8 min of untreated ventricular fibrillation. Brains were harvested for assessing serum inflammatory markers and neuronal damage at 24 h after ROSC. BV2 microglial underwent oxygen–glucose deprivation/reperfusion (OGD/R). Effects of OP on inflammatory responses, NF‐κB activation, cell viability, and the CD24‐Siglec‐G/10 interaction were evaluated using immunofluorescence, immunoprecipitation, molecular, and biochemical assays.Results: In vivo, OP attenuated pig cerebral microglial activation and neuronal integrity with attenuated neuroinflammation, alongside time‐dependent neuraminidase activity increases. In vitro, OP suppressed OGD/R‐induced microglial NF‐κB activation, reduced pro‐inflammatory cytokine levels, and preserved CD24‐Siglec‐G interaction, correlating with diminished neuraminidase release.Conclusions: OP as a repurposed immunomodulator that suppresses microglial‐driven neuroinflammation after CA by preserving sialylation‐dependent CD24‐Siglec‐G/10 interaction.
- 21 August 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (8) , e70495
Open AccessOseltamivir Phosphate Modulates CD24‐Siglec‐G/10 Interaction to Suppress Microglial‐Driven Neuroinflammation After Cardiac Arrest
Background: In cardiac arrest (CA) patients undergoing cardiopulmonary resuscitation (CPR), neuroinflammation following return of spontaneous circulation (ROSC) contributes to brain ischemia/reperfusion injury and neurological dysfunction. Recent evidence suggested that neuraminidase could exacerbate inflammatory responses by disrupting CD24‐Siglec‐G/10 immune checkpoint axis. As a neuraminidase inhibitor, oseltamivir phosphate (OP) holds potential for immunomodulation beyond its antiviral use. We aimed to investigate the impact and mechanism of OP on neuroinflammation regulation after ROSC.Methods: Male pigs were randomized into the sham control group, CPR, and CPR + OP group. CA was induced in pigs through 8 min of untreated ventricular fibrillation. Brains were harvested for assessing serum inflammatory markers and neuronal damage at 24 h after ROSC. BV2 microglial underwent oxygen–glucose deprivation/reperfusion (OGD/R). Effects of OP on inflammatory responses, NF‐κB activation, cell viability, and the CD24‐Siglec‐G/10 interaction were evaluated using immunofluorescence, immunoprecipitation, molecular, and biochemical assays.Results: In vivo, OP attenuated pig cerebral microglial activation and neuronal integrity with attenuated neuroinflammation, alongside time‐dependent neuraminidase activity increases. In vitro, OP suppressed OGD/R‐induced microglial NF‐κB activation, reduced pro‐inflammatory cytokine levels, and preserved CD24‐Siglec‐G interaction, correlating with diminished neuraminidase release.Conclusions: OP as a repurposed immunomodulator that suppresses microglial‐driven neuroinflammation after CA by preserving sialylation‐dependent CD24‐Siglec‐G/10 interaction.
- 9 December 2022
- Published by Elsevier in Cryobiology
- Vol. 110, 49-55
Effects of temperature control on hyperthermia-related cardiac dysfunction in a porcine model of cardiac arrest
- 9 December 2022
- Published by Elsevier in Cryobiology
- Vol. 110, 49-55
Effects of temperature control on hyperthermia-related cardiac dysfunction in a porcine model of cardiac arrest
- 25 August 2022
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (5) , 1957-1974
Mild Hypothermia Alleviates Complement C5a-Induced Neuronal Autophagy During Brain Ischemia–Reperfusion Injury After Cardiac Arrest
After restoration of spontaneous circulation (ROSC) following cardiac arrest, complements can be activated and excessive autophagy can contribute to the brain ischemia–reperfusion (I/R) injury. Mild hypothermia (HT) protects against brain I/R injury after ROSC, but the mechanisms have not been fully elucidated. Here, we found that HT significantly inhibited the increases in serum NSE, S100β, and C5a, as well as neurologic deficit scores, TUNEL-positive cells, and autophagic vacuoles in the pig brain cortex after ROSC. The C5a receptor 1 (C5aR1) mRNA and the C5a, C5aR1, Beclin 1, LC3-II, and cleaved caspase-3 proteins were significantly increased, but the P62 protein and the PI3K/Akt/mTOR pathway-related proteins were significantly reduced in pigs after ROSC or neuronal oxygen–glucose deprivation/reoxygenation. HT could significantly attenuate the above changes in NT-treated neurons. Furthermore, C5a treatment induced autophagy and apoptosis and reduced the PI3K/Akt/mTOR pathway-related proteins in cultured neurons, which could be reversed by C5aR1 antagonist PMX205. Our findings demonstrated that C5a could bind to C5aR1 to induce neuronal autophagy during the brain I/R injury, which was associated with the inhibited PI3K/Akt/mTOR pathway. HT could inhibit C5a-induced neuronal autophagy by regulating the C5a–C5aR1 interaction and the PI3K/Akt/mTOR pathway, which might be one of the neuroprotective mechanisms underlying I/R injury. Graphical Abstract The C5a receptor 1 (C5aR1) mRNA and the C5a, C5aR1, Beclin 1, LC3-II, and cleaved caspase-3 proteins were significantly increased, but the P62 protein and the PI3K/Akt/mTOR pathway-related proteins were significantly reduced in pigs after ROSC or neuronal oxygen–glucose deprivation/reoxygenation. Mild hypothermia (HT) could significantly attenuate the above changes in NT-treated neurons. Furthermore, C5a treatment induced autophagy and apoptosis and reduced the PI3K/Akt/mTOR pathway-related proteins in cultured neurons, which could be reversed by C5aR1 antagonist PMX205. Proposed mechanism by which HT protects against brain I/R injury by repressing C5a–C5aR1-induced excessive autophagy. Complement activation in response to brain I/R injury generates C5a that can interact with C5aR1 to inactivate mTOR, probably through the PI3K-AKT pathway, which can finally lead to autophagy activation. The excessively activated autophagy ultimately contributes to cell apoptosis and brain injury. HT may alleviate complement activation and then reduce C5a-induced autophagy to protect against brain I/R injury. HT, mild hypothermia; I/R, ischemia reperfusion.
- 25 August 2022
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (5) , 1957-1974
Mild Hypothermia Alleviates Complement C5a-Induced Neuronal Autophagy During Brain Ischemia–Reperfusion Injury After Cardiac Arrest
After restoration of spontaneous circulation (ROSC) following cardiac arrest, complements can be activated and excessive autophagy can contribute to the brain ischemia–reperfusion (I/R) injury. Mild hypothermia (HT) protects against brain I/R injury after ROSC, but the mechanisms have not been fully elucidated. Here, we found that HT significantly inhibited the increases in serum NSE, S100β, and C5a, as well as neurologic deficit scores, TUNEL-positive cells, and autophagic vacuoles in the pig brain cortex after ROSC. The C5a receptor 1 (C5aR1) mRNA and the C5a, C5aR1, Beclin 1, LC3-II, and cleaved caspase-3 proteins were significantly increased, but the P62 protein and the PI3K/Akt/mTOR pathway-related proteins were significantly reduced in pigs after ROSC or neuronal oxygen–glucose deprivation/reoxygenation. HT could significantly attenuate the above changes in NT-treated neurons. Furthermore, C5a treatment induced autophagy and apoptosis and reduced the PI3K/Akt/mTOR pathway-related proteins in cultured neurons, which could be reversed by C5aR1 antagonist PMX205. Our findings demonstrated that C5a could bind to C5aR1 to induce neuronal autophagy during the brain I/R injury, which was associated with the inhibited PI3K/Akt/mTOR pathway. HT could inhibit C5a-induced neuronal autophagy by regulating the C5a–C5aR1 interaction and the PI3K/Akt/mTOR pathway, which might be one of the neuroprotective mechanisms underlying I/R injury. Graphical Abstract The C5a receptor 1 (C5aR1) mRNA and the C5a, C5aR1, Beclin 1, LC3-II, and cleaved caspase-3 proteins were significantly increased, but the P62 protein and the PI3K/Akt/mTOR pathway-related proteins were significantly reduced in pigs after ROSC or neuronal oxygen–glucose deprivation/reoxygenation. Mild hypothermia (HT) could significantly attenuate the above changes in NT-treated neurons. Furthermore, C5a treatment induced autophagy and apoptosis and reduced the PI3K/Akt/mTOR pathway-related proteins in cultured neurons, which could be reversed by C5aR1 antagonist PMX205. Proposed mechanism by which HT protects against brain I/R injury by repressing C5a–C5aR1-induced excessive autophagy. Complement activation in response to brain I/R injury generates C5a that can interact with C5aR1 to inactivate mTOR, probably through the PI3K-AKT pathway, which can finally lead to autophagy activation. The excessively activated autophagy ultimately contributes to cell apoptosis and brain injury. HT may alleviate complement activation and then reduce C5a-induced autophagy to protect against brain I/R injury. HT, mild hypothermia; I/R, ischemia reperfusion.
- Open Access
- 8 July 2022
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2022 (7) , rjac290
Thymoma (World Health Organization Type AB) in multiple endocrine neoplasia type 1: a case report
Thymic neoplasms are rarely seen among patients with multiple endocrine neoplasia type 1 (MEN1) and appear to be especially rare when pathological examination reveals a World Health Organization Type AB thymoma. In the case presented here, we report a 39-year-old woman with Type AB thymoma in MEN1. A 7.8-cm-sized mediastinal mass was diagnosed as a thymic neoplasm by computed tomography. In addition, pituitary tumor and hypercalcemia from parathyroid hyperplasia were found. Therefore, the patient was clinically diagnosed with MEN1 syndrome and underwent surgical resection of thymic tumor. At the 1-year follow-up, the patient appeared to be healthy without any sign of reoccurrence. Despite its rare occurrence, our case provides us with a new awareness that thymoma may coexist with MEN1.
- 8 July 2022
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2022 (7) , rjac290
Open AccessThymoma (World Health Organization Type AB) in multiple endocrine neoplasia type 1: a case report
Thymic neoplasms are rarely seen among patients with multiple endocrine neoplasia type 1 (MEN1) and appear to be especially rare when pathological examination reveals a World Health Organization Type AB thymoma. In the case presented here, we report a 39-year-old woman with Type AB thymoma in MEN1. A 7.8-cm-sized mediastinal mass was diagnosed as a thymic neoplasm by computed tomography. In addition, pituitary tumor and hypercalcemia from parathyroid hyperplasia were found. Therefore, the patient was clinically diagnosed with MEN1 syndrome and underwent surgical resection of thymic tumor. At the 1-year follow-up, the patient appeared to be healthy without any sign of reoccurrence. Despite its rare occurrence, our case provides us with a new awareness that thymoma may coexist with MEN1.